![](/img/cover-not-exists.png)
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
Ganzinelli, Monica, Rulli, Eliana, Caiola, Elisa, Garassino, Marina Chiara, Broggini, Massimo, Copreni, Elena, Piva, Sheila, Longo, Flavia, Labianca, Roberto, Bareggi, Claudia, Fabbri, Maria Agnese, MVolume:
5
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/srep16331
Date:
December, 2015
File:
PDF, 656 KB
english, 2015